Concepedia
Statistics
Publications
6
Citations
360
H-Index
Active since
2007
Affiliations
Ovid Therapeutics (United States)(Current)
Tel Aviv University
Yale University
Amicus Therapeutics (United States)
Mathews Adera is an author at Ovid Therapeutics (United States) specializing in pharmacology, medicine, and lysosomal storage defects.
Publications per year
2007–2021
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Michael R. McClung, Robert R. Recker, Paul D. Miller et al. · Bone · 2007 · 177 citations
Medicine, Endocrinology, Bone Metabolism +11
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase
David G. Warnock, Daniel G. Bichet, Myrl Holida et al. · PLoS ONE · 2015 · 62 citations · Full text
Life Sciences, Pharmacokinetics, Pharmacology +17
Pharmacokinetics and Safety of Migalastat HCl and Effects on Agalsidase Activity in Healthy Volunteers
Franklin K. Johnson, Paul N. Mudd, Alexander Bragat et al. · Clinical Pharmacology in Drug Development · 2013 · 43 citations
Medicine, Clinical Pharmacokinetics, Pharmacology +12
Development of an adapted Clinical Global Impression scale for use in Angelman syndrome
Alexander Kolevzon, Pamela Ventola, Christopher J. Keary et al. · Journal of Neurodevelopmental Disorders · 2021 · 32 citations · Full text
Social Sciences, Psychiatry, Psychology +17
Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia
Ryan Dammerman, Sonnie Kim, Mathews Adera et al. · Clinical Pharmacology in Drug Development · 2018 · 26 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
1–5 of 6